Does surgery induce angiogenesis in breast cancer? Indirect evidence from relapse pattern and mammography paradox

International Journal of Surgery

Volumn 3, Issue 3, 2005, Pages 179-187

  Retsky, Michael ^a   Demicheli, Romano ^b   Hrushesky, William J M ^c  

^a BOSTON CHILDREN S HOSPITAL   (United States)

^b NATIONAL CANCER INSTITUTE   (Italy)

^c WJB Dorn VA Medical Center   (United States)

Author keywords

Angiogenesis; Breast cancer; Dormancy; Early detection; Mammography paradox; Surgery

Indexed keywords

ANGIOGENESIS INHIBITOR; GROWTH FACTOR;

ADULT; AGED; ANGIOGENESIS; ARTICLE; BIOLOGY; BREAST CANCER; BREAST TUMOR; CALCULATION; CANCER MORTALITY; CANCER RELAPSE; CANCER SCREENING; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DISEASE COURSE; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MAMMOGRAPHY; META ANALYSIS; POPULATION; POSTOPERATIVE COMPLICATION; PREDICTION; PRIORITY JOURNAL; SURGICAL WOUND; SYSTEMATIC REVIEW;

EID: 27644574454     PISSN: 17439191     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijsu.2005.08.002     Document Type: Article

References (59)

1. A. Jemal, T. Murray, E. Ward, A. Samuels, R.C. Tiwari, and A. Ghafoor Cancer statistics, 2005 CA Cancer J Clin 55 1 2005 Jan-Feb 10 30
2. M. Baum Breast cancer screening comes full circle J Natl Cancer Inst 96 20 2004 Oct 20 1490 1491
3. S. Shapiro Periodic screening for breast cancer: the HIP randomized controlled trial. Health Insurance Plan J Natl Cancer Inst Monogr 22 1997 27 30
4. L. Tabar, H. Chen, G. Fagerberg, S. Duffy, and T. Smith Recent results from the Swedish two-county trial: the effects of age, histologic type, and mode of detection on the efficacy of breast cancer screening J Natl Cancer Inst Monogr 22 1997 43 47
5. L.-G. Larsson, I. Anderson, N. Bjurstam, G. Fagerberg, J. Frisell, and L. Tabar Updated overview of the Swedish randomized trials on breast cancer screening with mammography: age group 40-49 at randomization J Natl Cancer Inst Monogr 22 1997 57 61
6. N. Bjurstam, L. Bjorneld, S.W. Duffy, T.C. Smith, E. Cahlin, and O. Erikson The Gothenburg breast cancer screening trial: preliminary results on breast cancer mortality for women aged 39-49 J Natl Cancer Inst Monogr 22 1997 53 55
7. F. Alexander The Edinburgh randomized trial of breast cancer screening, NIH consensus conference on breast cancer screening for women ages 40-49 J Natl Cancer Inst Monogr 31 1997 31 36
8. A. Miller, T. To, C. Baines, and C. Wall The Canadian national breast screening study: update on breast cancer mortality J Natl Cancer Inst Monogr 22 1997 37 41
9. A.B. Miller, T. To, C.J. Baines, and C. Wall The Canadian national breast screening study-1: breast cancer mortality after 11 to 16 years of follow-up. A randomized screening trial of mammography in women age 40 to 49 years Ann Intern Med 137 5 Part 1 2002 Sep 3 305 312
10. A.B. Miller, T. To, C.J. Baines, C.A.B. Wall, and C.J. Miller Baines Canadian national breast screening study-2: 13-year results of a randomized trial in women aged 50-59 years J Natl Cancer Inst 92 18 2000 Sep 20 1490 1499
11. B. Cox Variation in the effectiveness of breast screening by year of follow-up J Natl Cancer Inst Monogr 22 1997 69 72
12. S. Fletcher Breast cancer screening among women in their forties: an overview of the issues J Natl Cancer Inst Monogr 22 1997 5 9
13. G. Taubes The breast-screening brawl Science 275 5303 21 February 1997 1056 1059
14. NIH consensus development panel Consensus statement J Natl Cancer Inst Monogr 22 1997 vii
15. S.W. Fletcher Whither scientific deliberation in health policy recommendations? Alice in the Wonderland of breast-cancer screening N Engl J Med 336 16 1997 Apr 17 1180 1183
16. P. Gotzsche, and O. Olsen Is screening for breast cancer with mammography justifiable? Lancet 355 2000 129 134
17. M.W. Retsky, R. Demicheli, D.E. Swartzendruber, P.D. Bame, R.H. Wardwell, and G. Bonadonna Computer simulation of a breast cancer metastasis model Breast Cancer Res Treat 45 1997 193 202
18. R. Demicheli, M. Retsky, D. Swartzendruber, and G. Bonadonna Proposal for a new model of breast cancer metastatic development Ann Oncol 8 1997 1075 1080
19. M. Retsky, R. Demicheli, and W. Hrushesky Premenopausal status accelerates relapse in node positive breast cancer: hypothesis links angiogenesis, screening controversy Breast Cancer Res Treat 65 2001 217 224
20. E.R. Fisher, R. Sass, and B. Fisher Pathologic findings from the national adjuvant project for breast cancers (protocol no. 4) Cancer 53 3 Suppl. Feb. 1, 1984 712 723
21. T. Saphner, D.C. Tormey, and R. Gray Annual hazard rates of recurrence for breast cancer after primary therapy J Clin Oncol 14 1996 2738 2746
22. M. Baum, and R.A. Badwe Does surgery influence the natural history of breast cancer? H. Wise H.J. Johnson Breast cancer: controversies in management 1994 Futura Armonk, NY 61 69
23. J. Bedwinek Adjuvant irradiation for early breast cancer. An on-going controversy Cancer 53 3 Suppl. 1984 Feb 1 729 739
24. A. de la Rochefordiere, B. Asselain, F. Campana, S.M. Scholl, J. Fenton, and J.R. Vilcoq Age as prognostic factor in premenopausal breast carcinoma Lancet 341 8852 1993 Apr 24 1039 1043
25. U. Veronesi, E. Marubini, M. Del Vecchio, A. Manzari, S. Andreola, and M. Greco Local recurrences and distant metastases after conservative breast cancer treatments: partly independent events J Natl Cancer Inst 87 1 1995 Jan 4 19 27
26. A. Fortin, M. Larochelle, J. Laverdiere, S. Lavertu, and D. Tremblay Local failure is responsible for the decrease in survival for patients with breast cancer treated with conservative surgery and postoperative radiotherapy J Clin Oncol 17 1 1999 Jan 101 109
27. I. Jatoi, A. Tsimelzon, H. Weiss, G.M. Clark, and S.G. Hilsenbeck Hazard rates of recurrence following diagnosis of primary breast cancer Breast Cancer Res Treat 89 2 2005 Jan 173 178
28. S. Koscielny, and M. Tubiana The link between local recurrence and distant metastases in human breast cancer Int J Radiat Oncol Biol Phys 43 1 January 1999 11 24 [ http://www.sciencedirect.com/science/article/B6T7X-3VKT4DS- 4/2/c2b377a2fdebfa366a7d13561629f3da ]
29. L. Holmgren, M.S. O'Reilly, and J. Folkman Dormancy of micrometastases: balanced proliferation and apoptosis in the presence of angiogenesis suppression Nat Med 1 2 1995 Feb 149 153
30. N. Klauber-DeMore, K.J. Van Zee, I. Linkov, P.I. Borgen, and W.L. Gerald Biological behavior of human breast cancer micrometasteses Clin Cancer Res 7 2001 Aug 2434 2439
31. G.N. Naumov, I.C. MacDonald, P.M. Weinmeister, N. Kerkvliet, K.V. Nadkarni, and S.M. Wilson Persistence of solitary mammary carcinoma cells in a secondary site: a possible contributor to dormancy Cancer Res 62 April 1, 2002 2162 2168
32. G.N. Naumov, J.L. Townson, I.C. MacDonald, S.M. Wilson, V.H. Bramwell, and A.C. Groom Ineffectiveness of doxorubicin treatment on solitary dormant mammary carcinoma cells or late-developing metastases Breast Cancer Res Treat 82 3 2003 Dec 199 206
33. A. Meltzer Dormancy and breast cancer J Surg Oncol 43 3 1990 Mar 181 188
34. S. Meng, D. Tripathy, E.P. Frenkel, S. Shete, E.Z. Naftalis, and J.F. Huth Circulating tumor cells in patients with breast cancer dormancy Clin Cancer Res 10 24 2004 Dec 15 8152 8162
35. I.R. Hart Perspective: tumour spread-the problems of latency J Pathol 187 1 1999 Jan 91 94
36. M.S. O'Reilly, L. Holmgren, Y. Shing, C. Chen, R.A. Rosenthal, and M. Moses Angiostatin: a novel angiogenesis inhibitor that mediates the suppression of metastases by a Lewis lung carcinoma Cell 79 2 1994 315 328
37. J.C. Coffey, J.H. Wang, M.J. Smith, D. Bouchier-Hayes, T.G. Cotter, and H.P. Redmond Excisional surgery for cancer cure: therapy at a cost Lancet Oncol 4 12 2003 Dec 760 768
38. R. Wieder Insurgent micrometastases: sleeper cells and harboring the enemy J Surg Oncol 89 4 2005 Mar 15 207 210
39. T. Udagawa, A. Fernandez, E.G. Achilles, J. Folkman, and R.J. D'Amato Persistence of microscopic human cancers in mice: alterations in the angiogenic balance accompanies loss of tumor dormancy FASEB J 16 11 2002 Sep 1361 1370
40. S.O. Hofer, G. Molema, R.A. Hermens, H.J. Wanebo, J.S. Reichner, and H.J. Hoekstra The effect of surgical wounding on tumour development Eur J Surg Oncol 25 3 1999 Jun 231 243
41. J.L. Roh, M.W. Sung, and K.H. Kim Suppression of accelerated tumor growth in surgical wounds by celecoxib and indomethacin Head Neck 27 4 2005 Apr 326 332
42. L. Nystrom, I. Andersson, N. Bjurstam, J. Frisell, B. Nordenskjold, and L.E. Rutqvist Long-term effects of mammography screening: updated overview of the Swedish randomised trials Lancet 359 9310 2002 Mar 16 909 919
43. W.C. Black, D.A. Haggstrom, and H.G. Welch All-cause mortality in randomized trials of cancer screening J Natl Cancer Inst 94 3 2002 Feb 6 167 173
44. W.J.M. Hrushesky, A.Z. Bluming, S.A. Gruber, and R.B. Sothern Menstrual influence on surgical cure of breast cancer Lancet 338 1989 949 952
45. K. Heer, H. Kumar, V. Speirs, J. Greenman, P.J. Drew, and J.N. Fox Vascular endothelial growth factor in premenopausal women - indicator of the best time for breast cancer surgery? Br J Cancer 78 1998 1203 1207
46. P.A. Wood, and W.J. Hrushesky Sex cycle modulates cancer growth Breast Cancer Res Treat 91 1 2005 May 95 102
47. V. Stearns, and N.E. Davidson Deja vu for breast cancer two? J Natl Cancer Inst 96 7 2004 Apr 7 497 499
48. S. You, P.A. Wood, Y. Xiong, M. Kobayashi, J. Du-Quiton, and W.J.M. Hrushesky Daily coordination of cancer growth and circadian clock gene expression Breast Cancer Res Treat 91 1 May 2005 47 60
49. M. Baum, R. Demicheli, W. Hrushesky, and M. Retsky Does surgery unfavorably perturb the "natural history" of early breast cancer by accelerating the appearance of distant metastases? Eur J Cancer 41 4 2005 Mar 508 515
50. T. Gansler, S.J. Henley, K. Stein, E.J. Nehl, C. Smigal, and E. Slaughter Cancer. Sociodemographic determinants of cancer treatment health literacy Cancer 104 3 2005 Aug 1 653 660
51. M. Retsky, R. Demicheli, and W. Hrushesky Breast cancer screening: controversies and future directions Curr Opin Obstet Gynecol 15 2003 1 8
52. R. Demicheli, G. Bonadonna, W.J.M. Hrushesky, M.W. Retsky, and P. Valagussa Menopausal status dependence of the early mortality reduction due to diagnosing smaller breast cancers (T1 versus T2-T3): relevance to screening J Clin Oncol 22 1 Jan. 1, 2004 102 107
53. J.G. Elmore, L.M. Reisch, M.B. Barton, W.E. Barlow, S. Rolnick, and E.L. Harris Efficacy of breast cancer screening in the community according to risk level J Natl Cancer Inst 97 14 2005 Jul 20 1035 1043
54. C.J. Baines Mammography screening: are women really giving informed consent? J Natl Cancer Inst 95 20 2003 Oct 15 1508 1511
55. A.C. Von Eschenbach NCI remains committed to current mammography guidelines Oncologist 7 3 2002 170 171
56. R.A. Smith Breast cancer screening among women younger than age 50: a current assessment of the issues CA Cancer J Clin 50 5 2000 Sep-Oct 312 336
57. M. Retsky, G. Bonadonna, R. Demicheli, J. Folkman, W. Hrushesky, and P. Valagussa Hypothesis: induced angiogenesis after surgery in premenopausal node-positive breast cancer patients is a major underlying reason why adjuvant chemotherapy works particularly well for those patients Breast Cancer Res 6 2004 R372 R374
58. R. Demicheli, G. Bonadonna, W.J. Hrushesky, M.W. Retsky, and P. Valagussa Menopausal status dependence of the timing of breast cancer recurrence after surgical removal of the primary tumour Breast Cancer Res 6 6 2004 R689 R696 Epub 2004 Oct 11
59. G. Bonadonna, P. Valagussa, A. Moliterni, M. Zambetti, and C. Brambilla Adjuvant cyclophosphamide, methotrexate, and fluorouracil in node-positive breast cancer: the results of 20 years of follow-up N Engl J Med 332 14 1995 Apr 6 901 906